Anthony J Day Selected Research

Anthony J Day Research Topics

Disease

31	Inflammation (Inflammations) 01/2022 - 07/2002
16	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 08/2006
5	Arthritis (Polyarthritis) 01/2016 - 06/2003
4	Neoplasms (Cancer) 01/2022 - 02/2004
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 08/2014
3	Blindness (Hysterical Blindness) 01/2020 - 08/2006
3	Joint Diseases (Joint Disease) 01/2017 - 05/2002
2	Necrosis 03/2019 - 08/2007
2	Osteoarthritis 01/2017 - 05/2002
2	Cicatrix (Scar) 04/2012 - 06/2006
2	Asthma (Bronchial Asthma) 04/2007 - 01/2007
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Lung Diseases (Lung Disease) 01/2021
1	COVID-19 01/2021
1	Ulcerative Colitis 12/2019
1	Infections 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Gliosis 01/2016
1	Cataract (Cataracts) 01/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2016
1	Spasm (Spasms) 10/2015
1	Atypical Hemolytic Uremic Syndrome 03/2013
1	Bone Resorption 04/2011
1	Rheumatoid Arthritis 04/2011
1	Hypoxia (Hypoxemia) 04/2010
1	Carcinogenesis 04/2010
1	Hemolytic-Uremic Syndrome 05/2009
1	Neoplasm Metastasis (Metastasis) 02/2004
1	Female Infertility 05/2003

Drug/Important Bio-Agent (IBA)

23	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 05/2002
22	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
11	Complement System Proteins (Complement)IBA 01/2020 - 04/2007
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2002
11	Complement Factor H (Factor H)IBA 01/2018 - 08/2006
6	GlycosaminoglycansIBA 08/2014 - 07/2002
5	Carrier Proteins (Binding Protein)IBA 01/2016 - 04/2007
3	inter-alpha-inhibitorIBA 01/2007 - 09/2005
2	Retinaldehyde (Retinal)IBA 01/2018 - 09/2010
2	C-Reactive ProteinIBA 01/2018 - 04/2007
2	CytokinesIBA 01/2016 - 03/2014
2	Tyrosine (L-Tyrosine)FDA Link 04/2007 - 05/2005
2	Cell Surface ReceptorsIBA 02/2004 - 07/2002
2	Aggrecans (Aggrecan)IBA 06/2003 - 05/2002
2	Hyaluronan ReceptorsIBA 12/2002 - 07/2002
1	Versicans (Versican)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Interleukin-13IBA 01/2021
1	dupilumabIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Trace Elements (Biometals)IBA 12/2020
1	Proteoglycans (Proteoglycan)IBA 01/2020
1	Therapeutic UsesIBA 12/2019
1	PTX3 proteinIBA 03/2019
1	Hyaluronan SynthasesIBA 01/2019
1	Biocompatible Materials (Biomaterials)IBA 01/2017
1	LipidsIBA 01/2017
1	StreptavidinIBA 04/2016
1	AluminumIBA 01/2016
1	VanadiumIBA 01/2016
1	IonsIBA 01/2016
1	MetalsIBA 01/2016
1	Pharmaceutical PreparationsIBA 10/2015
1	Polysaccharides (Glycans)IBA 10/2015
1	Heparitin Sulfate (Heparan Sulfate)IBA 07/2014
1	Interleukin-6 (Interleukin 6)IBA 04/2011
1	Interleukin-1 (Interleukin 1)IBA 04/2011
1	EndostatinsIBA 04/2010
1	Shiga Toxin (Shigella Toxin)IBA 05/2009
1	Fibrinolysin FDA Link 09/2008
1	Fibronectins (Fibronectin)IBA 04/2008
1	Histidine (L-Histidine)FDA Link 04/2007
1	tyrosyltyrosine (Tyr-Tyr)IBA 04/2007
1	FibromodulinIBA 04/2007
1	histidylhistidine (His-His)IBA 04/2007
1	DNA (Deoxyribonucleic Acid)IBA 04/2007
1	AllergensIBA 01/2007
1	pre-alpha-trypsin inhibitorIBA 01/2007
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2007
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2007
1	Antigen-Antibody Complex (Immune Complex)IBA 08/2006
1	Heparin (Liquaemin)FDA LinkGeneric 08/2006
1	Blood Proteins (Serum Proteins)IBA 06/2006
1	SugarsIBA 05/2005
1	SolutionsIBA 12/2003
1	catechin gallateIBA 06/2003
1	EstersIBA 06/2003
1	EnzymesIBA 06/2003
1	LigandsIBA 07/2002

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2003
1	Debridement 01/2022
1	Lenses 01/2016
1	Transplantation 03/2014